Biorestorative Therapies Inc
(BRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 92 | 201 | 0 | 72 | 18 |
| Inventories | N/A | 18 | 13 | N/A | N/A |
| TOTAL | $114 | $240 | $31 | $118 | $18 |
| Non-Current Assets | |||||
| PPE Net | 494 | 36 | 59 | 95 | 447 |
| Intangibles | 1,038 | 1,108 | 1,177 | 3 | 4 |
| Other Non-Current Assets | 46 | 0 | 0 | 5 | 0 |
| TOTAL | $1,578 | $1,143 | $1,237 | $103 | $450 |
| Total Assets | $1,692 | $1,383 | $1,268 | $221 | $469 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,112 | 1,270 | 771 | 426 | 160 |
| Accrued Expenses | 1,561 | 1,243 | 1,083 | 440 | 342 |
| TOTAL | $8,525 | $7,503 | $2,816 | $3,907 | $1,016 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50 | 524 | 3,594 | N/A | 197 |
| Deferred Revenues | 164 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 5 | 41 | 0 | 0 | 0 |
| TOTAL | $55 | $565 | $3,594 | $N/A | $197 |
| Total Liabilities | $8,580 | $8,068 | $6,410 | $3,907 | $1,213 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11 | 7 | 246 | 194 | N/A |
| Common Shares | 2 | 20 | 15 | 636 | 461 |
| Retained earnings | -25,400 | -19,812 | -14,061 | -7,525 | -3,451 |
| Other shareholders' equity | -32 | -32 | -32 | -32 | -25 |
| TOTAL | $-6,888 | $-6,685 | $-5,142 | $-3,686 | $-744 |
| Total Liabilities And Equity | $1,692 | $1,383 | $1,268 | $221 | $469 |